Raydiant Oximetry Secures FDA Approval for Lumerah Investigational Device Exemption (IDE) Study The FDA has approved the Investigational Device Exemption (IDE) of Lumerah for an Early Feasibility Study (EFS) of pregnant women during labor and delivery